Emerging trends in combination strategies with phototherapy in advanced psoriasis management

[1]  Xiran Lin,et al.  Peroxisome proliferator-activator receptor γ and psoriasis, molecular and cellular biochemistry , 2022, Molecular and Cellular Biochemistry.

[2]  R. Watanabe,et al.  Skin-Resident Memory T Cells: Pathogenesis and Implication for the Treatment of Psoriasis , 2021, Journal of clinical medicine.

[3]  L. Stein Gold,et al.  New topical therapies for psoriasis , 2021, Dermatological Reviews.

[4]  Kranthi Jagadevapuram,et al.  Comparative study of PUVA and NB-UVB in the management of chronic plaque psoriasis , 2021, Indian Journal of Drugs in Dermatology.

[5]  Huiping Wang,et al.  Combination of retinoids and narrow-band ultraviolet B inhibits matrix metalloproteinase 13 expression in HaCaT keratinocytes and a mouse model of psoriasis , 2021, Scientific Reports.

[6]  S. Srivastava,et al.  Repurposing approved therapeutics for new indication: Addressing unmet needs in psoriasis treatment , 2021, Current research in pharmacology and drug discovery.

[7]  T. Gambichler,et al.  Efficacy and safety of fumaric acid esters in young patients aged 10–17 years with moderate‐to‐severe plaque psoriasis: a randomized, double‐blinded, placebo‐controlled trial * , 2020, The British journal of dermatology.

[8]  P. C. van de Kerkhof,et al.  Effectiveness and Safety of Systemic Therapy for Psoriasis in Older Adults: A Systematic Review. , 2020, JAMA dermatology.

[9]  L. Coates,et al.  Methotrexate in Psoriasis and Psoriatic Arthritis , 2020, The Journal of Rheumatology. Supplement.

[10]  Joanna H. Campbell.  Safe and effective use of phototherapy and photochemotherapy in the treatment of psoriasis. , 2020, British Journal of Nursing.

[11]  B. Moran,et al.  IL‐17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa , 2020, Clinical and experimental immunology.

[12]  S. Subramanian,et al.  A study to compare the efficacy and safety of narrow band-UVB alone as well as in combination with topical calcipotriol in patients with psoriasis vulgaris , 2020 .

[13]  A. E. Torres,et al.  Role of phototherapy in the era of biologics , 2020, Journal of the American Academy of Dermatology.

[14]  Ling Chen,et al.  Tissue-resident memory T cells and their biological characteristics in the recurrence of inflammatory skin disorders , 2019, Cellular & Molecular Immunology.

[15]  T. Kupper,et al.  T cells and the skin: from protective immunity to inflammatory skin disorders , 2019, Nature Reviews Immunology.

[16]  M. Schön.  Adaptive and Innate Immunity in Psoriasis and Other Inflammatory Disorders , 2019, Front. Immunol..

[17]  M. D'Arcy.  Cell death: a review of the major forms of apoptosis, necrosis and autophagy , 2019, Cell biology international.

[18]  P. Rojsitthisak,et al.  Synergistic Effects of Photo-Irradiation and Curcumin-Chitosan/Alginate Nanoparticles on Tumor Necrosis Factor-Alpha-Induced Psoriasis-Like Proliferation of Keratinocytes , 2019, Molecules.

[19]  Adriana Rendon,et al.  Psoriasis Pathogenesis and Treatment , 2019, International journal of molecular sciences.

[20]  A. Azizpour,et al.  Efficacy and safety of pioglitazone plus phototherapy versus phototherapy in patients with plaque type psoriasis: a Double Blinded Randomized Controlled Trial , 2018, The Journal of dermatological treatment.

[21]  A. Salman,et al.  Impact of psoriasis in the quality of life of children, adolescents and their families: a cross-sectional study* , 2018, Anais brasileiros de dermatologia.

[22]  T. Nomura,et al.  The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis , 2018, Nature Immunology.

[23]  M. Lebwohl,et al.  Review of safety and efficacy of approved systemic psoriasis therapies , 2018, International journal of dermatology.

[24]  V. Jain,et al.  Tazarotene gel with narrow-band UVB phototherapy: a synergistic combination in psoriasis* , 2018, Anais brasileiros de dermatologia.

[25]  M. Tan,et al.  Determinants of quality of life and psychological status in adults with psoriasis , 2018, Archives of Dermatological Research.

[26]  A. Geroldinger,et al.  Fumaric acid esters in combination with a 6‐week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate‐to‐severe plaque psoriasis: a randomized prospective clinical study , 2018, The British journal of dermatology.

[27]  A. Minagawa,et al.  Pathogenesis of psoriasis and development of treatment , 2018, The Journal of dermatology.

[28]  A. Morita.  Current developments in phototherapy for psoriasis , 2018, The Journal of dermatology.

[29]  Y. Tada,et al.  Safety of biologics in psoriasis , 2018, The Journal of dermatology.

[30]  V. Verallo-Rowell,et al.  Review Update on Topical Therapy for Psoriasis , 2018, Current Dermatology Reports.

[31]  Mei X. Wu,et al.  A clinical review of phototherapy for psoriasis , 2017, Lasers in Medical Science.

[32]  M. Gautam,et al.  Topical Therapies in Psoriasis , 2017, Indian dermatology online journal.

[33]  K. Reich,et al.  Efficacy and safety of fumaric acid esters in combination with phototherapy in patients with moderate‐to‐severe plaque psoriasis (FAST) , 2017, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[34]  P. Arora,et al.  Effect of narrow band ultraviolet B phototherapy on T helper 17 cell specific cytokines (interleukins-17, 22 and 23) in psoriasis vulgaris , 2017, The Journal of dermatological treatment.

[35]  J. Sak,et al.  A brief report on the history of phototherapy. , 2016, Clinical Dermatology.

[36]  J. Szepietowski,et al.  The effect of phototherapy on systemic inflammatory process in patients with plaque psoriasis. , 2016, Journal of photochemistry and photobiology. B, Biology.

[37]  V. Jain,et al.  Tacalcitol: A useful adjunct to narrow band ultraviolet B phototherapy in psoriasis , 2016, The Journal of dermatological treatment.

[38]  M. Lynch,et al.  Dipeptidyl peptidase-4 inhibition and narrow-band ultraviolet-B light in psoriasis (DINUP): study protocol for a randomised controlled trial , 2016, Trials.

[39]  S. Agrawal,et al.  Methotrexate plus narrow band ultraviolet B (NBUVB) versus methotrexate alone in the treatment of moderate to severe plaque psoriasis: A randomized clinical trial , 2016 .

[40]  Drew H Barnes,et al.  Cytokines in psoriasis. , 2015, Cytokine.

[41]  A. Nofal,et al.  Combination therapy of methotrexate plus NBUVB phototherapy is more effective than methotrexate monotherapy in the treatment of chronic plaque psoriasis , 2015, The Journal of dermatological treatment.

[42]  J. Koo,et al.  Supraerythemogenic excimer laser in combination with clobetasol spray and calcitriol ointment for the treatment of generalized plaque psoriasis: Interim results of an open label pilot study , 2015, The Journal of dermatological treatment.

[43]  H. Al-Hamamy,et al.  Comparative study of the effect of narrowband ultraviolet B phototherapy plus methotrexate vs. narrowband ultraviolet B alone and methotrexate alone in the treatment of plaque‐type psoriasis , 2014, International journal of dermatology.

[44]  P. Gahalaut,et al.  Clinical efficacy of psoralen + sunlight vs. combination of isotretinoin and psoralen + sunlight for the treatment of chronic plaque‐type psoriasis vulgaris: a randomized hospital‐based study , 2014, Photodermatology, photoimmunology & photomedicine.

[45]  M. Czarnecka-Operacz,et al.  The possibilities and principles of methotrexate treatment of psoriasis – the updated knowledge , 2014, Postepy dermatologii i alergologii.

[46]  M. Lynch,et al.  Sitagliptin for severe psoriasis , 2014, Clinical and experimental dermatology.

[47]  Mayte Suárez-Fariñas,et al.  Immunology of psoriasis. , 2014, Annual review of immunology.

[48]  S. Feldman,et al.  Systemic Therapies for Psoriasis: An Evidence-Based Update , 2014, American Journal of Clinical Dermatology.

[49]  R. Pouliot,et al.  Promising New Treatments for Psoriasis , 2013, TheScientificWorldJournal.

[50]  O. Shaker,et al.  Antiangiogenic Effect of Methotrexate and PUVA on Psoriasis , 2013, Cell Biochemistry and Biophysics.

[51]  Yau-Huei Wei,et al.  Molecular Mechanisms of UV-Induced Apoptosis and Its Effects on Skin Residential Cells: The Implication in UV-Based Phototherapy , 2013, International journal of molecular sciences.

[52]  W. Liao,et al.  Phototherapy in Psoriasis: A Review of Mechanisms of Action , 2013, Journal of cutaneous medicine and surgery.

[53]  H. Hönigsmann,et al.  History of phototherapy in dermatology , 2012, Photochemical & Photobiological Sciences.

[54]  P. Filipe,et al.  Mechanisms of Action of Topical Corticosteroids in Psoriasis , 2012, International journal of endocrinology.

[55]  O. Köse,et al.  Efficacy and safety of non‐laser, targeted UVB phototherapy alone and in combination with psoralen gel or calcipotriol ointment in the treatment of localized, chronic, plaque‐type psoriasis , 2012, International Journal of Dermatology.

[56]  A. Bewley,et al.  What is new in topical therapy for psoriasis? , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[57]  H. Young,et al.  Topical treatment of psoriasis , 2010, Expert opinion on pharmacotherapy.

[58]  A. Kanwar,et al.  Methotrexate/narrowband UVB phototherapy combination vs. narrowband UVB phototherapy in the treatment of chronic plaque‐type psoriasis – a randomized single‐blinded placebo‐controlled study , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[59]  M. Lebwohl,et al.  Topical corticosteroids in psoriasis: strategies for improving safety , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[60]  A. Gottlieb,et al.  Psoriasis comorbidities , 2008, The Journal of dermatological treatment.

[61]  James T. Elder,et al.  Psoriasis: epidemiology. , 2007, Clinics in dermatology.

[62]  L. Naldi,et al.  The clinical spectrum of psoriasis. , 2007, Clinics in dermatology.

[63]  James G. Krueger,et al.  Pathogenesis and therapy of psoriasis , 2007, Nature.

[64]  Daniel B. Shin,et al.  Prevalence of cardiovascular risk factors in patients with psoriasis. , 2022, Central European journal of public health.

[65]  M. Norval.  The mechanisms and consequences of ultraviolet-induced immunosuppression. , 2006, Progress in biophysics and molecular biology.

[66]  J. Barker,et al.  Psoriasis and its management , 2006, BMJ : British Medical Journal.

[67]  A. Neimann,et al.  Epidemiology of psoriasis , 2006, Oxford Medicine Online.

[68]  M. Lebwohl,et al.  Treatment of psoriasis. Part 2. Systemic therapies. , 2001, Journal of the American Academy of Dermatology.

[69]  U. Mrowietz.  Advances in systemic therapy for psoriasis , 2001, Clinical and experimental dermatology.

[70]  H. Hönigsmann,et al.  Phototherapy for psoriasis , 2001, Clinical and experimental dermatology.

[71]  J. Koo,et al.  Tazarotene plus UVB phototherapy in the treatment of psoriasis. , 2000, Journal of the American Academy of Dermatology.

[72]  B. Strober,et al.  Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with phototherapy. , 2019 .

[73]  Anjali Jain,et al.  Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[74]  Abolfazl Ezzati,et al.  Comparison between the effects of Daivonex cream alone and its combination with narrowband ultraviolet B in treatment of psoriasis , 2015 .

[75]  H. Matz.  Phototherapy for psoriasis: what to choose and how to use: facts and controversies. , 2010, Clinics in dermatology.